Blockade of the programmed death-1 (PD1) pathway undermines potent genetic protection from type 1 diabetes.
<h4>Aims/hypothesis</h4>Inhibition of PD1-PDL1 signaling in NOD mice accelerates onset of type 1 diabetes implicating this pathway in suppressing the emergence of pancreatic beta cell reactive T-cells. However, the molecular mechanism by which PD1 signaling protects from type 1 diabetes...
Saved in:
| Main Authors: | Nora M Kochupurakkal, Annie J Kruger, Sudipta Tripathi, Bing Zhu, La Tonya Adams, Daniel B Rainbow, Aldo Rossini, Dale L Greiner, Mohamed H Sayegh, Linda S Wicker, Indira Guleria |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089561&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Viral Infection: A Potent Barrier to Transplantation Tolerance
by: David M. Miller, et al.
Published: (2008-01-01) -
PD‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
by: Abul Azad, et al.
Published: (2016-12-01) -
Undermining competition, undermining markets? Implications of Big Tech and digital personal data for competition policy
by: Kean Birch, et al.
Published: (2025-03-01) -
Blockade of IL-1 family cytokines in the treatment of rheumatoid arthritis
by: Kexin Wang, et al.
Published: (2025-05-01) -
Basic rules to respond to PD-1 blockade cancer immunotherapy
by: Antoni Ribas
Published: (2025-05-01)